BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20605117)

  • 1. [Leptin: a peptide with therapeutic potential in the obese].
    González Jiménez E; Aguilar Cordero MJ; García García Cde J; García López PA; Alvarez Ferre J; Padilla López CA
    Endocrinol Nutr; 2010; 57(7):322-7. PubMed ID: 20605117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of leptin in the regulation of energy balance].
    Sousa M; Brás-Silva C; Leite-Moreira A
    Acta Med Port; 2009; 22(3):291-8. PubMed ID: 19686630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leptin: from gene to energy balance].
    Basdevant A; Ciangura C
    Bull Acad Natl Med; 2007; 191(4-5):887-94; discussion 894-5. PubMed ID: 18225443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.
    Fam BC; Morris MJ; Hansen MJ; Kebede M; Andrikopoulos S; Proietto J; Thorburn AW
    Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MONA LISA hypothesis in the time of leptin.
    Bray GA; York DA
    Recent Prog Horm Res; 1998; 53():95-117; discussion 117-8. PubMed ID: 9769705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin resistance in obesity: An epigenetic landscape.
    Crujeiras AB; Carreira MC; Cabia B; Andrade S; Amil M; Casanueva FF
    Life Sci; 2015 Nov; 140():57-63. PubMed ID: 25998029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance.
    Berthoud HR
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():197S-200S. PubMed ID: 17021366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and its metabolic interactions: an update.
    Anubhuti ; Arora S
    Diabetes Obes Metab; 2008 Nov; 10(11):973-93. PubMed ID: 18284436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between estrogen and leptin signaling in the hypothalamus.
    Gao Q; Horvath TL
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E817-26. PubMed ID: 18334610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-hormonal control of food intake: basic mechanisms and clinical implications.
    Konturek PC; Konturek JW; Cześnikiewicz-Guzik M; Brzozowski T; Sito E; Konturek SJ
    J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():5-25. PubMed ID: 16340035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leptin--the metabolic signal from adipose tissue].
    Kulik-Rechberger B
    Przegl Lek; 2003; 60(1):35-9. PubMed ID: 12884645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into amylin-leptin synergy.
    Trevaskis JL; Parkes DG; Roth JD
    Trends Endocrinol Metab; 2010 Aug; 21(8):473-9. PubMed ID: 20413324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new biology of body weight regulation.
    Schwartz MW; Seeley RJ
    J Am Diet Assoc; 1997 Jan; 97(1):54-8; quiz 59-60. PubMed ID: 8990418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain regulation of food intake and expenditure energy: molecular action of insulin, leptin and physical exercise].
    Cintra DE; Ropelle ER; Pauli JR
    Rev Neurol; 2007 Dec 1-15; 45(11):672-82. PubMed ID: 18050100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cachexia and obesity: two sides of one coin?
    Inui A; Meguid MM
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):395-9. PubMed ID: 12806212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system control of food intake.
    Schwartz MW; Woods SC; Porte D; Seeley RJ; Baskin DG
    Nature; 2000 Apr; 404(6778):661-71. PubMed ID: 10766253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin: obesity, diabetes and other peripheral effects--a review.
    Moran O; Phillip M
    Pediatr Diabetes; 2003 Jun; 4(2):101-9. PubMed ID: 14655266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the neuroendocrine control of energy homeostasis by adiposity signals during aging.
    Carrascosa JM; Ros M; Andrés A; Fernández-Agulló T; Arribas C
    Exp Gerontol; 2009; 44(1-2):20-5. PubMed ID: 18572339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).
    Challis BG; Coll AP; Yeo GS; Pinnock SB; Dickson SL; Thresher RR; Dixon J; Zahn D; Rochford JJ; White A; Oliver RL; Millington G; Aparicio SA; Colledge WH; Russ AP; Carlton MB; O'Rahilly S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4695-700. PubMed ID: 15070780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
    N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.